Ra Capital Management, L.p. sold $3.4M of VOR
director, owner at Vor Biopharma Inc.. 117,050 shares at an average of $29.34, traded Oct 20, 2025, filed Oct 22, 2025.
Score components
- +15RoleDirector
- +25Trade size$3.4M at market
- 0Share of holdings soldSold 7.8% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -71.9%, 3m -31.8%, 6m -42.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-25-000342, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 20, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -70,366 | $29.63 | $2.1M | 1,432,806 | Oct 22, 2025 |
| Oct 20, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -13,817 | $29.63 | $409k | 1,287 | Oct 22, 2025 |
| Oct 20, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -6,553 | $30.12 | $197k | 1,426,253 | Oct 22, 2025 |
| Oct 20, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -1,287 | $30.12 | $39k | 0 | Oct 22, 2025 |
| Oct 21, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -25,027 | $28.11 | $704k | 1,401,226 | Oct 22, 2025 |
Related signals
Other insiders at Vor Biopharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. owner | $4,207 213 shares | -0% | |
| 40Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $2.6M 165,150 shares | -6% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $10M 630,374 shares | -20% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $12M 737,989 shares | -19% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $10M 620,133 shares | -14% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $15M 849,257 shares | -16% | |
| 58Moderate | Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $10M 400,408 shares | -34% | |
| 53Moderate | Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $6.2M 221,166 shares | -16% | |
| 45Moderate | Vor Biopharma Inc. | Reprogrammed Interchange LLC owner | $1.1M 37,533 shares | -3% | |
| 45Moderate | Vor Biopharma Inc. | Reprogrammed Interchange LLC owner | $2.3M 73,676 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.